Anthropic acquires one-person drug startup Mithril Medicine

Anthropic has acquired Mithril Medicine, a one-person startup developing treatments for two rare forms of muscular dystrophy. The AI developer is also working with Bristol Myers Squibb, BigHat Biosciences and four other partners on drug discovery.

• Anthropic acquired Mithril Medicine, a one-person drug startup
• Mithril is developing treatments for two rare muscular dystrophies
• Anthropic is working with Bristol Myers Squibb and BigHat Biosciences
• The company has six drug-discovery partners in total